“⚖베스트토토안전【평생베스트.com】베스트토토안전확인⚖”的搜索结果，显示 121-130 项，共有 12355 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... best supportive care (BSC)) on protocol survivor follow up) in patients with advanced non-ocular melanoma. Prospective Use of Philips iSuite for ...

2. 外科 - 临床试验- 妙佑医疗国际

   Research is instrumental for improving medical care and the patient experience. Finding new surgical techniques can create better outcomes and minimize ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This phase I/II trial studies the side effects and best dose of romidepsin and lenalidomide when combined with rituximab and to see how well this ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to identify the side effects and best dose of abemaciclib when given together with olaparib in treating patients with ovarian ...

5. CAR-T 细胞疗法计划- 临床试验- 妙佑医疗国际

   The purpose of this study is to determine the safety and best dose of PRGN-3006 T Cells to treat relapsed/refractory Acute Myeloid Leukemia and High Risk ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to identify the side effects and best dose of abemaciclib when given together with olaparib in treating patients with ovarian ...

7. 内分泌科- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to explore how using different terms (with or without the word cancer) to identify papillary thyroid cancer might ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to determine the safety and best dose of PRGN-3006 T Cells to treat relapsed/refractory Acute Myeloid Leukemia and High Risk ...

9. 妙佑医疗国际眼科- 临床试验

   To determine the effectiveness of the ARTISAN Aphakia lens in the treatment of aphakia and to precisely define the associated risks and, if possible, ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    ... best overall response rate (BORR) of combined ramucirumab (RAM) plus paclitaxel (+/- pembrolizumab) following induction pembrolizumab (PEM) in patients with ...